Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BIO-RAD LABORATORIES, INC.

(BIO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Bio Rad Laboratories : Q2 Adjusted Earnings More Than Double as Revenue Improves

07/29/2021 | 05:29pm EDT


ę MT Newswires 2021
All news about BIO-RAD LABORATORIES, INC.
10/19BIO RAD LABORATORIES : Commissioner's Decision 1590 – Inputs, Outputs And Everything..
AQ
10/15BIO RAD LABORATORIES : Rad to Report Third-Quarter 2021 Financial Results, Thursday, Octob..
BU
10/04BIO-RAD LABORATORIES, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
10/04Bio-Rad Laboratories, Inc. Announces Executive Changes, Effective January 4, 2022
CI
08/31BIO RAD LABORATORIES : Rad to Participate in the 2021 Virtual Wells Fargo Healthcare Confe..
BU
08/0310X GENOMICS : After Intense Patent Litigation Bio-Rad And 10x Genomics Settle Through Cro..
AQ
07/30BIO RAD LABORATORIES : Management's Discussion and Analysis of Financial Condition and Res..
AQ
07/30Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on Novembe..
CI
07/30SECTOR UPDATE : Health Care Stocks Scratching Out Small Advance Just Ahead of Friday Close
MT
07/30SECTOR UPDATE : Health Care Stocks Posting Modest Friday Advance
MT
More news
Analyst Recommendations on BIO-RAD LABORATORIES, INC.
More recommendations
Financials (USD)
Sales 2021 2 845 M - -
Net income 2021 486 M - -
Net cash 2021 1 174 M - -
P/E ratio 2021 47,5x
Yield 2021 -
Capitalization 22 588 M 22 588 M -
EV / Sales 2021 7,53x
EV / Sales 2022 7,32x
Nbr of Employees 8 000
Free-Float 70,8%
Chart BIO-RAD LABORATORIES, INC.
Duration : Period :
Bio-Rad Laboratories, Inc. Technical Analysis Chart | BIO | US0905722072 | MarketScreener
Technical analysis trends BIO-RAD LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 764,62 $
Average target price 771,25 $
Spread / Average Target 0,87%
EPS Revisions
Managers and Directors
Norman D. Schwartz Chairman, President & Chief Executive Officer
Ilan Daskal Chief Financial Officer & Executive Vice President
Andrew J. Last Chief Operating Officer & Executive Vice President
Jeffrey L. Edwards Independent Director
Gregory K. Hinckley Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BIO-RAD LABORATORIES, INC.32.63%22 588
ABBOTT LABORATORIES16.64%226 407
MEDTRONIC PLC4.58%164 862
BECTON, DICKINSON AND COMPANY-2.09%70 362
HOYA CORPORATION21.16%56 045
DEXCOM, INC.51.07%54 038